2016 | Tunisia | Health & Pharmaceuticals | Social-economic development
Development Strategy for human drugs exports
Context & objectives:
Despite an increase in exports to 15% per annum, the pharmaceutical sector represents less than 0.2% of Tunisia's exports. Public and private actors want to define the 2030 ambitions in terms of exports, and this in the following public-private dialogue on the competitiveness of the pharmaceutical sector, organized in 2014.
The project strives to
Main achievements & impacts
Identification of 2 scenarios and their impacts:Optimization of the existing and search for new markets relatively easy to access Transformation of the drug sector to export more than imported by 2030 If these two scenarios are not put in place, there is a risk of regression where Tunisia would lose its current position in terms of drug exports.
